. 2016 Jun 16;113(27):E3950–E3959. doi: 10.1073/pnas.1601747113

Table S2.

Pharmacology of dual-tagged GluA2-CFP/YFP receptors

	l-glutamate	CTZ	DNQX
Receptor	EC₅₀,^† μM	EC₅₀,^† μM	IC₅₀,^† nM
WT GluA2	28 [27–31]	6 [5–9]	1154 [857–1552]
GluA2-0Y-6C	81 [66–100]	11 [8–15]	562 [391–809]
GluA2-0Y-10C	30 [27–33]	9 [6–13]	845 [308–2598]
GluA2-3Y-6C	108 [99–117]^*	7 [5–10]	156 [90–271]^*
GluA2-3Y-10C	25 [22–29]	9 [7–11]	444 [234–843]
GluA2-6Y-10C	46 [41–50]	12 [10–15]	163 [50–535]^*

P < 0.05 value statistically significantly different from WT GluA2.

^{^†}

Data represent EC₅₀ or IC₅₀ obtained from fitting of composite dose–response data (Fig. S1) from experiments at five to nine oocytes (95% confidence intervals in brackets).